A pill that mimics the body's oxygen sensor may free MDS patients from frequent blood transfusions
Disease control
Not yet recruiting
This phase 3 trial tests whether roxadustat, an oral drug that stimulates red blood cell production, can help people with myelodysplastic syndromes (MDS) who need frequent blood transfusions. Participants with very low, low, or intermediate risk MDS and a high transfusion burden …
Phase: PHASE3 • Sponsor: Kyntra Bio • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC